Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Feb 2016 for TriVascular Technologies, Inc.. Read the official filing
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
New Enterprise Associates 12, Limited Partnership: trading record in brief
This profile gathers the share dealings of New Enterprise Associates 12, Limited Partnership across 2 companies, led by Ardelyx, Inc. and TriVascular Technologies, Inc. In total, 2 filings cover trades dated from 13 January 2016 to 3 February 2016.
No open-market sale appears; the market trades are 1 purchase. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Most recently, on 4 February 2016, the filings show a transaction in TriVascular Technologies, Inc. The most recent open-market purchase was published on 14 January 2016, 3,929 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to New Enterprise Associates 12, Limited Partnership
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
3,943,269 sharesCommon StockSEC:0001209191-16-095748:0
500,000 sharesCommon StockSEC:0001209191-16-091421:0
Canonical exit: 12 Apr 2016 (T+90)
2 of 2 declarations
